Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005819 | spindle | 5 | 1 |
GO:0005930 | axoneme | 2 | 1 |
GO:0043226 | organelle | 2 | 3 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0072686 | mitotic spindle | 6 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 3 |
GO:0005929 | cilium | 4 | 2 |
GO:0031514 | motile cilium | 5 | 2 |
GO:0042995 | cell projection | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 2 |
Related structures:
AlphaFold database: A4HPK0
Term | Name | Level | Count |
---|---|---|---|
GO:0000226 | microtubule cytoskeleton organization | 3 | 1 |
GO:0000281 | mitotic cytokinesis | 4 | 1 |
GO:0000910 | cytokinesis | 3 | 1 |
GO:0001539 | cilium or flagellum-dependent cell motility | 3 | 1 |
GO:0006996 | organelle organization | 4 | 1 |
GO:0007010 | cytoskeleton organization | 5 | 1 |
GO:0007017 | microtubule-based process | 2 | 1 |
GO:0007051 | spindle organization | 3 | 1 |
GO:0007052 | mitotic spindle organization | 4 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0016043 | cellular component organization | 3 | 1 |
GO:0022402 | cell cycle process | 2 | 1 |
GO:0048870 | cell motility | 2 | 1 |
GO:0060285 | cilium-dependent cell motility | 4 | 1 |
GO:0061640 | cytoskeleton-dependent cytokinesis | 4 | 1 |
GO:0071840 | cellular component organization or biogenesis | 2 | 1 |
GO:1902850 | microtubule cytoskeleton organization involved in mitosis | 4 | 1 |
GO:1903047 | mitotic cell cycle process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005488 | binding | 1 | 1 |
GO:0005515 | protein binding | 2 | 1 |
GO:0008092 | cytoskeletal protein binding | 3 | 1 |
GO:0015631 | tubulin binding | 4 | 1 |
GO:0043014 | alpha-tubulin binding | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 301 | 305 | PF00656 | 0.564 |
CLV_MEL_PAP_1 | 185 | 191 | PF00089 | 0.421 |
CLV_NRD_NRD_1 | 120 | 122 | PF00675 | 0.535 |
CLV_NRD_NRD_1 | 364 | 366 | PF00675 | 0.528 |
CLV_NRD_NRD_1 | 64 | 66 | PF00675 | 0.583 |
CLV_PCSK_KEX2_1 | 120 | 122 | PF00082 | 0.556 |
CLV_PCSK_KEX2_1 | 246 | 248 | PF00082 | 0.582 |
CLV_PCSK_KEX2_1 | 364 | 366 | PF00082 | 0.528 |
CLV_PCSK_KEX2_1 | 64 | 66 | PF00082 | 0.583 |
CLV_PCSK_PC1ET2_1 | 246 | 248 | PF00082 | 0.639 |
CLV_PCSK_SKI1_1 | 215 | 219 | PF00082 | 0.511 |
DOC_CKS1_1 | 44 | 49 | PF01111 | 0.628 |
DOC_PP4_FxxP_1 | 189 | 192 | PF00568 | 0.651 |
DOC_PP4_FxxP_1 | 236 | 239 | PF00568 | 0.636 |
DOC_USP7_MATH_1 | 196 | 200 | PF00917 | 0.532 |
DOC_USP7_MATH_1 | 203 | 207 | PF00917 | 0.534 |
DOC_USP7_MATH_1 | 311 | 315 | PF00917 | 0.711 |
DOC_USP7_MATH_1 | 318 | 322 | PF00917 | 0.698 |
DOC_USP7_UBL2_3 | 226 | 230 | PF12436 | 0.642 |
DOC_WW_Pin1_4 | 192 | 197 | PF00397 | 0.459 |
DOC_WW_Pin1_4 | 43 | 48 | PF00397 | 0.519 |
LIG_14-3-3_CanoR_1 | 364 | 372 | PF00244 | 0.353 |
LIG_14-3-3_CanoR_1 | 64 | 70 | PF00244 | 0.389 |
LIG_APCC_ABBAyCdc20_2 | 96 | 102 | PF00400 | 0.614 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.656 |
LIG_BRCT_BRCA1_1 | 232 | 236 | PF00533 | 0.481 |
LIG_BRCT_BRCA1_1 | 350 | 354 | PF00533 | 0.455 |
LIG_FHA_1 | 103 | 109 | PF00498 | 0.554 |
LIG_FHA_1 | 112 | 118 | PF00498 | 0.565 |
LIG_FHA_1 | 149 | 155 | PF00498 | 0.628 |
LIG_FHA_1 | 208 | 214 | PF00498 | 0.621 |
LIG_FHA_1 | 30 | 36 | PF00498 | 0.596 |
LIG_FHA_1 | 324 | 330 | PF00498 | 0.733 |
LIG_FHA_2 | 267 | 273 | PF00498 | 0.721 |
LIG_FHA_2 | 29 | 35 | PF00498 | 0.567 |
LIG_FHA_2 | 299 | 305 | PF00498 | 0.585 |
LIG_FHA_2 | 307 | 313 | PF00498 | 0.517 |
LIG_FHA_2 | 326 | 332 | PF00498 | 0.463 |
LIG_FHA_2 | 43 | 49 | PF00498 | 0.562 |
LIG_LIR_Apic_2 | 233 | 239 | PF02991 | 0.557 |
LIG_LIR_Gen_1 | 380 | 387 | PF02991 | 0.441 |
LIG_LIR_Nem_3 | 380 | 386 | PF02991 | 0.441 |
LIG_MLH1_MIPbox_1 | 350 | 354 | PF16413 | 0.475 |
LIG_MYND_1 | 16 | 20 | PF01753 | 0.666 |
LIG_SH2_GRB2like | 4 | 7 | PF00017 | 0.626 |
LIG_SH2_PTP2 | 344 | 347 | PF00017 | 0.501 |
LIG_SH2_SRC | 4 | 7 | PF00017 | 0.689 |
LIG_SH2_STAP1 | 100 | 104 | PF00017 | 0.606 |
LIG_SH2_STAT5 | 116 | 119 | PF00017 | 0.497 |
LIG_SH2_STAT5 | 262 | 265 | PF00017 | 0.696 |
LIG_SH2_STAT5 | 344 | 347 | PF00017 | 0.459 |
LIG_SH2_STAT5 | 353 | 356 | PF00017 | 0.460 |
LIG_SH3_3 | 127 | 133 | PF00018 | 0.577 |
LIG_SH3_3 | 160 | 166 | PF00018 | 0.594 |
LIG_SH3_3 | 41 | 47 | PF00018 | 0.422 |
LIG_SUMO_SIM_anti_2 | 160 | 165 | PF11976 | 0.528 |
LIG_TRAF2_1 | 394 | 397 | PF00917 | 0.540 |
LIG_WRC_WIRS_1 | 50 | 55 | PF05994 | 0.622 |
MOD_CK1_1 | 150 | 156 | PF00069 | 0.531 |
MOD_CK1_1 | 199 | 205 | PF00069 | 0.682 |
MOD_CK1_1 | 375 | 381 | PF00069 | 0.459 |
MOD_CK1_1 | 391 | 397 | PF00069 | 0.589 |
MOD_CK1_1 | 85 | 91 | PF00069 | 0.437 |
MOD_CK2_1 | 266 | 272 | PF00069 | 0.726 |
MOD_CK2_1 | 28 | 34 | PF00069 | 0.571 |
MOD_CK2_1 | 391 | 397 | PF00069 | 0.512 |
MOD_GlcNHglycan | 178 | 182 | PF01048 | 0.632 |
MOD_GlcNHglycan | 192 | 195 | PF01048 | 0.653 |
MOD_GlcNHglycan | 201 | 204 | PF01048 | 0.519 |
MOD_GlcNHglycan | 207 | 210 | PF01048 | 0.629 |
MOD_GlcNHglycan | 283 | 286 | PF01048 | 0.730 |
MOD_GlcNHglycan | 290 | 293 | PF01048 | 0.699 |
MOD_GlcNHglycan | 301 | 304 | PF01048 | 0.689 |
MOD_GlcNHglycan | 312 | 316 | PF01048 | 0.718 |
MOD_GlcNHglycan | 320 | 323 | PF01048 | 0.600 |
MOD_GlcNHglycan | 390 | 393 | PF01048 | 0.347 |
MOD_GSK3_1 | 111 | 118 | PF00069 | 0.624 |
MOD_GSK3_1 | 192 | 199 | PF00069 | 0.634 |
MOD_GSK3_1 | 203 | 210 | PF00069 | 0.537 |
MOD_GSK3_1 | 25 | 32 | PF00069 | 0.596 |
MOD_GSK3_1 | 258 | 265 | PF00069 | 0.719 |
MOD_GSK3_1 | 273 | 280 | PF00069 | 0.707 |
MOD_N-GLC_1 | 196 | 201 | PF02516 | 0.574 |
MOD_NEK2_1 | 228 | 233 | PF00069 | 0.626 |
MOD_NEK2_1 | 253 | 258 | PF00069 | 0.731 |
MOD_NEK2_1 | 273 | 278 | PF00069 | 0.405 |
MOD_NEK2_1 | 325 | 330 | PF00069 | 0.602 |
MOD_NEK2_1 | 35 | 40 | PF00069 | 0.614 |
MOD_PIKK_1 | 111 | 117 | PF00454 | 0.621 |
MOD_PIKK_1 | 148 | 154 | PF00454 | 0.631 |
MOD_PIKK_1 | 207 | 213 | PF00454 | 0.616 |
MOD_PIKK_1 | 4 | 10 | PF00454 | 0.690 |
MOD_PK_1 | 71 | 77 | PF00069 | 0.410 |
MOD_PKA_1 | 364 | 370 | PF00069 | 0.470 |
MOD_PKA_2 | 111 | 117 | PF00069 | 0.585 |
MOD_PKA_2 | 248 | 254 | PF00069 | 0.670 |
MOD_PKA_2 | 364 | 370 | PF00069 | 0.470 |
MOD_Plk_1 | 375 | 381 | PF00069 | 0.378 |
MOD_Plk_1 | 71 | 77 | PF00069 | 0.442 |
MOD_Plk_2-3 | 266 | 272 | PF00069 | 0.726 |
MOD_Plk_4 | 150 | 156 | PF00069 | 0.584 |
MOD_Plk_4 | 258 | 264 | PF00069 | 0.709 |
MOD_ProDKin_1 | 192 | 198 | PF00069 | 0.458 |
MOD_ProDKin_1 | 43 | 49 | PF00069 | 0.519 |
MOD_SUMO_rev_2 | 346 | 354 | PF00179 | 0.605 |
MOD_SUMO_rev_2 | 391 | 401 | PF00179 | 0.557 |
TRG_ENDOCYTIC_2 | 158 | 161 | PF00928 | 0.663 |
TRG_ENDOCYTIC_2 | 344 | 347 | PF00928 | 0.459 |
TRG_ER_diArg_1 | 247 | 250 | PF00400 | 0.501 |
TRG_ER_diArg_1 | 363 | 365 | PF00400 | 0.512 |
TRG_NLS_MonoExtN_4 | 245 | 250 | PF00514 | 0.486 |
TRG_Pf-PMV_PEXEL_1 | 358 | 362 | PF00026 | 0.498 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6N3 | Leptomonas seymouri | 64% | 100% |
A0A1X0P414 | Trypanosomatidae | 41% | 97% |
A0A3Q8IKI9 | Leishmania donovani | 86% | 100% |
A0A422NVL8 | Trypanosoma rangeli | 41% | 98% |
A4ID64 | Leishmania infantum | 86% | 100% |
D0A8L4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 34% | 98% |
E9ATB2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 100% |
Q4Q185 | Leishmania major | 86% | 100% |
V5B6X3 | Trypanosoma cruzi | 39% | 96% |